ibrutinib
Not Tagged
['lymsm', 'ts,perio,i', 'cll', 'ts,perio,1']
congress| #asco23 jennifer woyach discusses results from a trial evaluating ivo response-guided discontinuation vs io indefinite treatment in cll patients. results so far show pfs is not superior for ivo vs io but covid-19 may have impacted this outcome #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm